AIDS Vaccine 2012 Embargo and Press Release Policies
Embargoes on reporting on studies presented at AIDS Vaccine 2012 lift at the conclusion of the session in which the study is presented. For example, if a study is presented from 11:15 to 11:30, as part of a session that ends at 12 noon, the embargo on reporting on that study lifts at 12 noon.
Conference embargoes will be strictly enforced. Violations of the conference embargo policy will result in revocation of the news organization's credentials to cover the meeting.
Press releases, fact sheets or any other materials designed to facilitate media coverage of research studies presented at AIDS Vaccine 2012 may only be distributed after the conclusion of the session in which the study is presented. For example, if a study is presented from 11:15 to 11:30 as part of a session that ends at 12 noon, press releases or other media materials may be distributed at 12 noon. If multiple studies are addressed in one release, that release may distributed at the time of the latest embargo lift.
Institutions public or private that believe they are compelled to communicate about a study prior to its presentation at AIDS Vaccine 2012, whether for reasons of disclosure of material data, notification of study participants, or any other reason must notify the Conference Secretariat and receive written approval prior to any public communication. If permission is granted, institutions may issue a press release with general findings (omitting full data to be presented at the meeting) prior to the conference.
Please direct any inquiries about conference embargo and press release policies to:
- Jennifer Brunet at +1 212-461-3693 (office); +1-917-207-9330 (mobile) or email@example.com